CoreCap Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$840 Buy
92
+51
+124% +$569 ﹤0.01% 2736
2026
Q1
$446 Hold
41
﹤0.01% 2669
2025
Q4
$249 Buy
41
+1
+3% +$6 ﹤0.01% 2788
2025
Q3
$208 Buy
40
+1
+3% +$6 ﹤0.01% 2667
2025
Q2
$235 Sell
39
-93
-70% -$560 ﹤0.01% 2606
2025
Q1
$1.09K Buy
132
+93
+238% +$780 ﹤0.01% 2510
2024
Q4
$320 Buy
39
+1
+3% +$8 ﹤0.01% 2614
2024
Q3
$293 Buy
+38
New +$350 ﹤0.01% 2427
2024
Q2
Sell
-38
Closed -$450 2344
2024
Q1
$450 Buy
+38
New +$422 ﹤0.01% 2346
2022
Q4
$614 Buy
+36
New +$594 ﹤0.01% 2133
2022
Q3
Sell
-36
Closed -$1K 1685
2022
Q2
$1K Buy
+36
New +$605 ﹤0.01% 2038

Other funds holding PTEN

CoreCap Advisors's PTEN Position: Q2 2026 in Review

CoreCap Advisors increased its Patterson-UTI (PTEN) stake by 124% in Q2 2026, buying an estimated $569 and bringing the position to 92 shares worth $840. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

CoreCap Advisors first reported a position in PTEN in Q2 2022 and has held it in 11 quarters since. The position peaked at $1.09K in Q1 2025. 38 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • CoreCap Advisors held 92 shares of Patterson-UTI worth $840 as of Q2 2026.
  • CoreCap Advisors bought 51 Patterson-UTI shares in Q2 2026, an estimated $569.
  • Patterson-UTI made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2736 holding.
  • CoreCap Advisors first reported a position in Patterson-UTI in Q2 2022 and has held it in 11 quarters since.
  • CoreCap Advisors's Patterson-UTI position peaked at $1.09K in Q1 2025.
  • 38 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.